# Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients

> **NCT02099175** · PHASE2 · UNKNOWN · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 41 (actual)

## Conditions studied

- Sinonasal Tumors

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Docetaxel
- **DRUG:** 5-fluorouracil
- **DRUG:** Etoposide
- **DRUG:** Adriamycin
- **DRUG:** Ifosfamide
- **DRUG:** Leucovorin
- **RADIATION:** Radiotherapy - Patients needing Elective Nodal Volume (ENI)
- **RADIATION:** Radiotherapy - Patients not needing ENI
- **RADIATION:** Radiotherapy - Patients needing curative neck irradiation

## Key facts

- **NCT ID:** NCT02099175
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2020-01
- **Final completion:** 2024-01
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2023-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02099175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02099175, "Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02099175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*